Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations

Home | Back to Search Results

Product Details for NDA 018609

Expand all

HEPARIN SODIUM 1,000 UNITS AND SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER (HEPARIN SODIUM)
200 UNITS/100ML
Marketing Status: Prescription

Active Ingredient: HEPARIN SODIUM
Proprietary Name: HEPARIN SODIUM 1,000 UNITS AND SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER
Dosage Form; Route of Administration: INJECTABLE; INJECTION
Strength: 200 UNITS/100ML
Reference Listed Drug: No
Reference Standard: No
TE Code: AP
Application Number: N018609
Product Number: 001
Approval Date: Apr 28, 1982
Applicant Holder Full Name: BAXTER HEALTHCARE CORP
Marketing Status:  Prescription
Patent and Exclusivity Information

HEPARIN SODIUM 2,000 UNITS AND SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER (HEPARIN SODIUM)
200 UNITS/100ML
Marketing Status: Prescription

Active Ingredient: HEPARIN SODIUM
Proprietary Name: HEPARIN SODIUM 2,000 UNITS AND SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER
Dosage Form; Route of Administration: INJECTABLE; INJECTION
Strength: 200 UNITS/100ML
Reference Listed Drug: No
Reference Standard: No
TE Code: AP
Application Number: N018609
Product Number: 002
Approval Date: Apr 28, 1982
Applicant Holder Full Name: BAXTER HEALTHCARE CORP
Marketing Status:  Prescription
Patent and Exclusivity Information

HEPARIN SODIUM 5,000 UNITS AND SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER (HEPARIN SODIUM)
500 UNITS/100ML
Marketing Status: Discontinued

Active Ingredient: HEPARIN SODIUM
Proprietary Name: HEPARIN SODIUM 5,000 UNITS AND SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER
Dosage Form; Route of Administration: INJECTABLE; INJECTION
Strength: 500 UNITS/100ML
Reference Listed Drug: No
Reference Standard: No
TE Code: 
Application Number: N018609
Product Number: 003
Approval Date: Apr 28, 1982
Applicant Holder Full Name: BAXTER HEALTHCARE CORP
Marketing Status:  Discontinued
Patent and Exclusivity Information